ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It

June 16, 1978

ACCR Considers Foriend Membership, Meeting With ASCO

June 14, 1991